Literature DB >> 25588743

Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike.

D J M van den Wollenberg1, I J C Dautzenberg1, W Ros1, A D Lipińska2, S K van den Hengel1, R C Hoeben1.   

Abstract

The capacity to modify the reovirus genome facilitates generation of new therapeutic reoviruses. We describe a method for generating replication-competent reoviruses carrying a heterologous transgene. The strategy is based on the expanded-tropism reovirus mutant jin-3, which can infect cells independent of the reovirus receptor junction-adhesion molecule A (JAM-A). Jin-3 harbors a mutation in the S1 segment, resulting in a G196R substitution in the tail of the spike protein σ1. The use of the jin-3 tail-encoding S1 segment allows replacing the codons for the JAM-A-binding head domain by up to 522  nucleotides of foreign sequences, without exceeding the size of the wild-type S1 segment. We inserted the codons for the porcine teschovirus-1 2A element fused with those encoding the fluorescent protein iLOV. Replicating rS1His-2A-iLOV reoviruses were generated by co-transfection of expression plasmids for all reovirus segments. These reoviruses contain the S1His-2A-iLOV segment in the absence of the wild-type S1 segment. Density-gradient centrifugation confirmed the association of the σ1-tail fragment with the capsid. Both JAM-A-positive and -negative cells exposed to the rS1His-2A-iLOV reoviruses exhibited iLOV fluorescence, confirming the jin-3-derived expanded-tropism phenotype. These data demonstrated the feasibility of generating decapitated replication-competent T3D reoviruses carrying a heterologous transgene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25588743     DOI: 10.1038/gt.2014.126

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  45 in total

1.  Design and construction of 2A peptide-linked multicistronic vectors.

Authors:  Andrea L Szymczak-Workman; Kate M Vignali; Dario A A Vignali
Journal:  Cold Spring Harb Protoc       Date:  2012-02-01

2.  Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1.

Authors:  J D Chappell; V L Gunn; J D Wetzel; G S Baer; T S Dermody
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1.

Authors:  K L Tyler; M K Squier; S E Rodgers; B E Schneider; S M Oberhaus; T A Grdina; J J Cohen; T S Dermody
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Nonstructural protein σ1s mediates reovirus-induced cell cycle arrest and apoptosis.

Authors:  Karl W Boehme; Katharina Hammer; William C Tollefson; Jennifer L Konopka-Anstadt; Takeshi Kobayashi; Terence S Dermody
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

5.  Mammalian orthoreovirus T3D infects U-118 MG cell spheroids independent of junction adhesion molecule-A.

Authors:  I J C Dautzenberg; D J M van den Wollenberg; S K van den Hengel; R W A Limpens; M Bárcena; A J Koster; R C Hoeben
Journal:  Gene Ther       Date:  2014-04-17       Impact factor: 5.250

6.  Structural tuning of the fluorescent protein iLOV for improved photostability.

Authors:  John M Christie; Kenichi Hitomi; Andrew S Arvai; Kimberly A Hartfield; Marcel Mettlen; Ashley J Pratt; John A Tainer; Elizabeth D Getzoff
Journal:  J Biol Chem       Date:  2012-05-09       Impact factor: 5.157

7.  The 3' sequences required for incorporation of an engineered ssRNA into the Reovirus genome.

Authors:  Michael R Roner; Joanne Roehr
Journal:  Virol J       Date:  2006-01-03       Impact factor: 4.099

Review 8.  Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics.

Authors:  K J Harrington; R G Vile; A Melcher; J Chester; H S Pandha
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-12       Impact factor: 7.638

9.  Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.

Authors:  Diana J M van den Wollenberg; Iris J C Dautzenberg; Sanne K van den Hengel; Steve J Cramer; Raoul J de Groot; Rob C Hoeben
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  An infectious recombinant foot-and-mouth disease virus expressing a fluorescent marker protein.

Authors:  Julian Seago; Nicholas Juleff; Katy Moffat; Stephen Berryman; John M Christie; Bryan Charleston; Terry Jackson
Journal:  J Gen Virol       Date:  2013-04-04       Impact factor: 3.891

View more
  12 in total

1.  Development of Stable Rotavirus Reporter Expression Systems.

Authors:  Yuta Kanai; Takahiro Kawagishi; Ryotaro Nouda; Misa Onishi; Pimfhun Pannacha; Jeffery A Nurdin; Keiichiro Nomura; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Characterization of a Replicating Mammalian Orthoreovirus with Tetracysteine-Tagged μNS for Live-Cell Visualization of Viral Factories.

Authors:  Luke D Bussiere; Promisree Choudhury; Bryan Bellaire; Cathy L Miller
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

3.  Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.

Authors:  Takahiro Kawagishi; Yuta Kanai; Ryotaro Nouda; Ichika Fukui; Jeffery A Nurdin; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

4.  African Swine Fever Virus NP868R Capping Enzyme Promotes Reovirus Rescue during Reverse Genetics by Promoting Reovirus Protein Expression, Virion Assembly, and RNA Incorporation into Infectious Virions.

Authors:  Heather E Eaton; Takeshi Kobayashi; Terence S Dermody; Randal N Johnston; Philippe H Jais; Maya Shmulevitz
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

5.  In Vivo Live Imaging of Oncolytic Mammalian Orthoreovirus Expressing NanoLuc Luciferase in Tumor Xenograft Mice.

Authors:  Yuta Kanai; Takahiro Kawagishi; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

6.  Reovirus Neurotropism and Virulence Are Dictated by Sequences in the Head Domain of the Viral Attachment Protein.

Authors:  Danica M Sutherland; Pavithra Aravamudhan; Melanie H Dietrich; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 7.  Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus.

Authors:  Vera Kemp; Rob C Hoeben; Diana J M van den Wollenberg
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

8.  Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery.

Authors:  Vera Kemp; Iris J C Dautzenberg; Ronald W Limpens; Diana J M van den Wollenberg; Rob C Hoeben
Journal:  Viruses       Date:  2017-09-21       Impact factor: 5.048

Review 9.  Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection.

Authors:  Tarryn Bourhill; Yoshinori Mori; Derrick E Rancourt; Maya Shmulevitz; Randal N Johnston
Journal:  Viruses       Date:  2018-08-11       Impact factor: 5.048

Review 10.  Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.

Authors:  Adil Mohamed; Randal N Johnston; Maya Shmulevitz
Journal:  Viruses       Date:  2015-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.